Lilly's mirikizumab, once a contender for psoriasis, bolsters case for UC indication in maintenance trial data readout

Press/Media

Period	24 May 2022

Media coverage

Title	Lilly's mirikizumab, once a contender for psoriasis, bolsters case for UC indication in maintenance trial data readout
Media name/outlet	Endpts.com
Country/Territory	United States
Date	24/05/22
URL	https://endpts.com/lillys-mirikizumab-once-a-contender-for-psoriasis-bolsters-case-for-uc-indication-in-maintenance-trial-data-readout
Persons	Marla Dubinsky